Dr John Chen is a post-doctoral research scientist in the Precision Nucleic Acid Therapeutics (PNAT) Research Group led by Associate Professor Rakesh Veedu at Murdoch University and Perron Institute. His PhD, undertaken in the PNAT group at CMMIT, focused on developing antisense therapies for Duchenne muscular dystrophy (DMD) and type 2 diabetes. John studied Biotechnology at the University of Queensland, where his focus was on aptamer development. As a post-doctoral researcher, his passion is in developing novel nucleic acid-based therapeutics for solid cancers and DMD.

View Publications    Email